Breaking News

Defense Department Launches Innovation Pathways Website > U.S. Department of Defense > Release Border Patrol Rescues Family from Potentially Disastrous Circumstance Maritime Women of Boston: Canadian Nurses in the 1920 Women’s Voter Registers U.S. Department of Agriculture Announces Key Staff Appointments SHIPBUILDER NOTIFIES CARNIVAL CRUISE LINE THAT CARNIVAL JUBILEE DELIVERY WILL BE DELAYED DHS Announces Registration Process for Temporary Protected Status for Ethiopia Raider Unveiled, Airmen Fly HEXA, Turning Flowers into Tires > Air Force > Article Display Attorney General James Announces Arrests in New York City Deed Theft Ring
Albuquerque, NM - Attorney General Hector Balderas and 41 other attorneys general yesterday filed an amended antitrust lawsuit against the makers of Suboxone, a prescription drug used to treat opioid addiction, over allegations that the companies engaged in a scheme to block generic competitors and cause purchasers to pay artificially high prices. Reckitt Benckiser Pharmaceuticals, now known as Indivior, is accused of conspiring with MonoSol Rx to switch Suboxone from a tablet version to a film (that dissolves in the mouth) in order to prevent or delay generic alternatives and maintain monopoly profits.

Source link